• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PF 05180999

CAS No. 1394033-54-5

PF 05180999 ( PF-05180999;PF05180999;PF 5180999 )

产品货号. M11643 CAS No. 1394033-54-5

PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
25MG ¥2558 有现货
50MG ¥4322 有现货
100MG 获取报价 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PF 05180999
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM.
  • 产品描述
    PF-05180999 (PF 5180999) is a potent, selective, brain-penetrating and orally bioavailable phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 1 nM; displays >1,000-fold selectivity over PDE10; shows potential for treatment of schizophrenia.Schizophrenia Phase 1 Discontinued
  • 同义词
    PF-05180999;PF05180999;PF 5180999
  • 通路
    Angiogenesis
  • 靶点
    PDE
  • 受体
    PDE
  • 研究领域
    Neurological Disease
  • 适应症
    Schizophrenia

化学信息

  • CAS Number
    1394033-54-5
  • 分子量
    414.40
  • 分子式
    C19H17F3N8
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : 50 mg/mL 120.66 mM
  • SMILES
    FC(C1=CN=C(C2=C(C3=C4C(N5CCC5)=NC=NN4C(C)=N3)C=NN2C)C=C1)(F)F
  • 化学全称
    4-(1-Azetidinyl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]-imidazo[5,1-f][1,2,4]triazine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Mikami S, et al. J Med Chem. 2017 Sep 28;60(18):7677-7702.
2. Helal CJ, et al. J Med Chem. 2018 Jan 2. doi: 10.1021/acs.jmedchem.7b01466.
产品手册
关联产品
  • Homo Sildenafil

    Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.

  • Diprophylline

    Dyphylline is a xanthine derivative with bronchodilator and vasodilator effects.

  • Difamilast

    Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM).